Rosen; Mark D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rosen; Mark D..The latest application filed is for "benzimidazole derivative for use in the treatment of inflammatory disorders".
Company Profile
7.22.27
- Rosen; Mark D. - San Diego CA
- Rosen; Mark D - San Diego CA US
Patent Activity
| Patent | Date |
|---|---|
| Benzimidazole Derivative For Use In The Treatment Of Inflammatory Disorders App 20210369678 - Rabinowitz; Michael ; et al. | 2021-12-02 |
| 4-aminoquinazolinyl compounds as prolyl hydroxylase inhibitors Grant 10,975,062 - Rabinowitz , et al. April 13, 2 | 2021-04-13 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20210078978 - Hocutt; Frances Meredith ; et al. | 2021-03-18 |
| Benzoimidazoles as prolyl hydroxylase inhibitors Grant 10,851,083 - Hocutt , et al. December 1, 2 | 2020-12-01 |
| 4-aminoquinazolinyl Compounds As Prolyl Hydroxylase Inhibitors App 20200095234 - Rabinowitz; Michael H. ; et al. | 2020-03-26 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20190367486 - Hocutt; Frances Meredith ; et al. | 2019-12-05 |
| 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors Grant 10,246,442 - Rabinowitz , et al. | 2019-04-02 |
| Flap modulators Grant 10,047,101 - Eccles , et al. August 14, 2 | 2018-08-14 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20180215732 - Hocutt; Frances Meredith ; et al. | 2018-08-02 |
| 4-aminoquinazolin Compounds As Prolyl Hydroxylase Inhibitors App 20180148435 - RABINOWITZ; Michael H. ; et al. | 2018-05-31 |
| Flap modulators Grant 9,926,333 - Eccles , et al. March 27, 2 | 2018-03-27 |
| FLAP modulators Grant 9,884,878 - Bacani , et al. February 6, 2 | 2018-02-06 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20180022733 - Hocutt; Frances Meredith ; et al. | 2018-01-25 |
| Flap Modulators App 20170327514 - Eccles; Wendy ; et al. | 2017-11-16 |
| 4-aminoquinazolin Compounds As Prolyl Hydroxylase Inhibitors App 20170320859 - RABINOWITZ; Michael H. ; et al. | 2017-11-09 |
| Flap modulators Grant 9,745,328 - Bacani , et al. August 29, 2 | 2017-08-29 |
| FLAP modulators Grant 9,732,093 - Eccles , et al. August 15, 2 | 2017-08-15 |
| 4-aminoquinazolinyl-2-yl-1-pyrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors Grant 9,573,940 - Rabinowitz , et al. February 21, 2 | 2017-02-21 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20160168127 - Hocutt; Frances Meredith ; et al. | 2016-06-16 |
| Flap Modulators App 20150376212 - BACANI; GENESIS M. ; et al. | 2015-12-31 |
| Flap Modulators App 20150368270 - Eccles; Wendy ; et al. | 2015-12-24 |
| Benzoimidazoles as prolyl hydroxylase inhibitors App 20150284335 - Hocutt; Frances Meredith ; et al. | 2015-10-08 |
| Flap Modulators App 20150259357 - Bacani; Genesis M. ; et al. | 2015-09-17 |
| Flap Modulators App 20150252008 - Eccles; Wendy ; et al. | 2015-09-10 |
| 4-Aminoquinazolinyl compounds as prolyl hydroxylase inhibitors App 20150197507 - Rabinowitz; Michael H. ; et al. | 2015-07-16 |
| Flap modulators Grant 9,079,866 - Bacani , et al. July 14, 2 | 2015-07-14 |
| Flap modulators Grant 9,073,876 - Eccles , et al. July 7, 2 | 2015-07-07 |
| Benzoimidazoles as prolyl hydroxylase inhibitors Grant 9,073,923 - Hocutt , et al. July 7, 2 | 2015-07-07 |
| 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors Grant 9,006,251 - Rabinowitz , et al. April 14, 2 | 2015-04-14 |
| Quinazolinones as prolyl hydroxylase inhibitors Grant 8,937,078 - Bembenek , et al. January 20, 2 | 2015-01-20 |
| Benzoimidazoles as prolyl hydroxylase inhibitors Grant 8,865,713 - Hocutt , et al. October 21, 2 | 2014-10-21 |
| 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic Acid Compounds As Prolyl Hydroxylase Inhibitors App 20140309215 - RABINOWITZ; Michael H. ; et al. | 2014-10-16 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20140256722 - HOCUTT; Frances Meredith ; et al. | 2014-09-11 |
| Flap Modulators App 20140221311 - Bacani; Genesis M. ; et al. | 2014-08-07 |
| Flap Modulators App 20140221310 - Eccles; Wendy ; et al. | 2014-08-07 |
| 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors Grant 8,796,263 - Rabinowitz , et al. August 5, 2 | 2014-08-05 |
| Benzoimidazoles as prolyl hydroxylase inhibitors Grant 8,759,345 - Hocutt , et al. June 24, 2 | 2014-06-24 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20140005193 - Hocutt; Frances Meredith ; et al. | 2014-01-02 |
| 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic Acid Compounds As Prolyl Hydroxylase Inhibitors App 20130143871 - Rabinowitz; Michael H. ; et al. | 2013-06-06 |
| Benzoimidazoles As Prolyl Hydroxylase Inhibitors App 20110046132 - Hocutt; Frances Meredith ; et al. | 2011-02-24 |
| Quinazolinones As Prolyl Hydroxylase Inhibitors App 20100204226 - Bembenek; Scott D. ; et al. | 2010-08-12 |
| Quinoxaline compounds Grant 7,563,895 - Allison , et al. July 21, 2 | 2009-07-21 |
| Quinoxaline Compounds App 20080076918 - Allison; Brett D. ; et al. | 2008-03-27 |
| Quinoxaline compounds Grant 7,304,051 - Allison , et al. December 4, 2 | 2007-12-04 |
| Quinoxaline compounds App 20050038032 - Allison, Brett D. ; et al. | 2005-02-17 |
Company Registrations
| SEC | 0001652467 | ROSEN MARK D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 